Evidence map›Paper›PMID 34497119›Full record

ArticleMolecular cancer research : MCR2021

lncRNA BORG:TRIM28 Complexes Drive Metastatic Progression by Inducing α6 Integrin/CD49f Expression in Breast Cancer Stem Cells.

Kimberly A Parker, Alex J Gooding, Saba Valadkhan, William P Schiemann

Open access · hybridAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Long non-coding RNAs: Key regulators of stemness in breast cancer.Frontiers in cell and developmental biology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. TRIM28 in cancer and cancer therapy.Frontiers in genetics · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Long non-coding RNAs in breast cancer stem cells.Medical oncology (Northwood, London, England) · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kimberly A Parker *Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio.ORCID 0000-0003-4438-3245
Alex J Gooding *Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.
Saba ValadkhanDepartment of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio.ORCID 0000-0002-6859-4883
William P SchiemannCase Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio. william.schiemann@case.edu.ORCID 0000-0002-0338-2636
Case Western Reserve University · US

Funding

PREDOCTORAL TRAINING PROGRAM IN MOLECULAR THERAPEUTICST32GM008803 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI MIEYAL, JOHN J, NIEMAN, MARVIN THOMAS · 2001 to 2023
$4.2M
Role of the lncRNA BORG in Breast Cancer Metastatic Progression and RecurrenceR01CA236273 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI SCHIEMANN, WILLIAM, VALADKHAN, SABA · 2019 to 2023
$2.3M
BORG: Role for a Novel lncRNA in Mediating Breast Cancer Metastasis and DormancyF30CA203233 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GOODING, ALEX JOSEPH · 2016 to 2019
$197k
IncRNA BORG Mediates Alternative Splicing to Enhance Cellular Plasticity in TNBCF31CA257637 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI PARKER, KIMBERLY · 2021 to 2022
$50k
NCI NIH HHS F30 CA203233NCI NIH HHS F31 CA257637NCI NIH HHS R01 CA236273NIGMS NIH HHS T32 GM008803
6 · The paper itself

Abstract

Triple-negative breast cancer (TNBC) is the most lethal subtype of breast cancer, with its aggressive phenotype being attributed to chemotherapy resistance, metastatic dissemination, and rapid disease recurrence. Breast cancer stem cells (BCSC) are significant contributors to tumor initiation, as well as to the acquisition of aggressive tumorigenic phenotypes, namely due to their ability to self-replicate and to produce heterogeneous differentiated tumor cells. To elucidate the underlying mechanisms that drive BCSC tumorigenicity in TNBC, we identified the long noncoding RNA (lncRNA)

Indexed as

AnimalsCell ProliferationDisease ProgressionHumansIntegrin alpha6MiceNeoplasm MetastasisNeoplastic Stem CellsRNA, Long NoncodingTripartite Motif-Containing Protein 28Integrin alpha6RNA, Long NoncodingTrim28 protein, mouseTripartite Motif-Containing Protein 28

Identifiers

PMID34497119
PMCPMC8642309
OpenAlexW3198330626

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.